03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Viramune Tablets* : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Boehringer Ingelheim |
Responsible Party | Boehringer Ingelheim International GmbH |
Origin | Germany |
Manufacturer | Boehringer Ingelheim Ellas A.E. |
Origin | Greece |
ATC | J05AG01 |
Viramune Tablets* :
Viramune Tablets* :
Viramune Tablets* :
Viramune Tablets* :
Viramune Tablets* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
ALT increased | Common |
Anaemia | Uncommon |
Anaphylactic reactions | Common |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Common |
Arthralgia (Pain joint) (Joint ache) | Uncommon |
AST increased | Common |
Autoimmune disorder | Not known |
Basedow's disease | Not known |
Blood alkaline phosphatase increased | Not known |
Blood bilirubin increased | Not known |
Blood phosphorus decreased | Uncommon |
Blood pressure increased | Uncommon |
Body fat disorder | Not known |
Breast enlargement | Not known |
Diarrhoea (Diarrhea) | Common |
DRESS (Drug reaction with eosinophilia and systemic symptoms) | Uncommon |
Eosinophilia | Not known |
Facial wasting | Not known |
Fat redistribution | Not known |
Fatigue | Common |
Gamma-GT increased | Common |
Granulocytopenia | Common |
Headache | Common |
Hepatic enzyme increased | Common |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Not known |
Hepatitis | Common |
Hepatitis fulminant | Rare |
Hepatorenal failure | Rare |
Hepatotoxicity (liver toxicity) | Common |
Hypercholesterolaemia | Not known |
Hyperglycaemia | Not known |
Hyperlactacidaemia | Not known |
Hypersensitivity | Common |
Hypertransaminasaemia | Common |
Hypertriglyceridaemia | Not known |
Immune reconstitution inflammatory syndrome | Not known |
Insulin resistance | Not known |
Jaundice | Uncommon |
Lipodystrophy acquired | Not known |
Lipohypertrophy | Not known |
Liver function test abnormal | Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Uncommon |
Lymphadenopathy | Not known |
Maculopapular rash | Not known |
Myalgia | Common |
Nausea | Common |
Neuropathy peripheral | Not known |
Osteonecrosis | Not known |
Pancreatitis | Not known |
Pyrexia | Common |
Renal impairment | Not known |
Skin rash | Very Common |
Stevens-Johnson syndrome | Uncommon |
Thrombocytopenia (Thrombopenia) | Not known |
Transaminases increased | Common |
Urticaria | Common |
Vomiting | Common |
Viramune Tablets* :
NB : Products With Same Indication |
Different Units By MoH Code
Viramune Tablets* MoH 6321 :
Form | Tablet |
Package Size | Box of 60 |
Strength | 200mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 166753/11 |
Submission date | 01/01/2011 |
Registration Year | 2011 |
Archived Date | 2018 |
Withdrawn Date | 13/06/2024 |
Price Comparison
● Country: | Finland | |
● Package Size: | 60 | |
● Public Price: | 477.07 EUR | ( 46,216,633.32 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 7,9512 EUR | ( 678,132.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Iceland | |
● Package Size: | 14 | |
● Public Price: | 11818 ISK | ( 7,622,610.00 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 844,1429 ISK | ( 544,380.00 LBP ) |
● Pharmacy Price: | 7524 ISK | ( 4852980 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 01/01/2019 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 60 | |
● Public Price: | 311.3 CHF | ( 32,194,646.00 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 5,1883 CHF | ( 517,100.00 LBP ) |
● Exfactory Price: | 256.88 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Denmark | |
● Package Size: | 14 | |
● Public Price: | 516.7 DKK | ( 6,704,699.20 LBP ) |
● Pack size unit used: | 14 | |
● Cost/Unit: | 36,9071 DKK | ( 467,136.00 LBP ) |
● Pharmacy Price: | 379.09 DKK | ( 4919071.84 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Oman | |
● Package Size: | 60 | |
● Public Price: | 127.72 OMR | ( 29,469,346.48 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 2,1287 OMR | ( 461,468.00 LBP ) |
● Pricing Date: | 02/07/2018 | |
● Type: | Medicine Non Marketed |
● Country: | Qatar | |
● Package Size: | 60 | |
● Public Price: | 1133 QAR | ( 27,824,214.00 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 18,8833 QAR | ( 442,044.00 LBP ) |
● Pharmacy Price: | 930.80061048 QAR | ( 22858601.392168 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 60 | |
● Public Price: | 1058.5 AED | ( 25,574,418.50 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 17,6417 AED | ( 410,737.00 LBP ) |
● Pharmacy Price: | 902 AED | ( 21793222 LBP ) |
● Pricing Date: | 16/11/2019 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 60 | |
● Public Price: | 1038.15 SAR | ( 24,541,866.00 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 17,3025 SAR | ( 401,880.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Italy | |
● Package Size: | 60 | |
● Public Price: | 268.27 EUR | ( 25,988,924.52 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 4,4712 EUR | ( 387,504.00 LBP ) |
● Exfactory Price: | 162.55 EUR | |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 60 | |
● Public Price: | 2170.1 NOK | ( 17,586,490.40 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 36,1683 NOK | ( 291,744.00 LBP ) |
● Pharmacy Price: | 1673.6 NOK | ( 13562854.4 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Withdrawn |
● Country: | Sweden | |
● Package Size: | 60 | |
● Public Price: | 1933.25 SEK | ( 16,254,766.00 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 32,2208 SEK | ( 269,056.00 LBP ) |
● Pharmacy Price: | 1850 SEK | ( 15554800 LBP ) |
● Pricing Date: | 23/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 60 | |
● Public Price: | 107.82 BHD | ( 25,632,479.88 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 1,797 BHD | ( 237,734.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 18/11/2017 | |
● Type: | Medicine Non Marketed |
● Country: | UK | |
● Package Size: | 60 | |
● Public Price: | 170 GBP | ( 19,320,330.00 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 2,8333 GBP | ( 227,298.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Withdrawn |
● Country: | Cyprus | |
● Package Size: | 60 TABS | |
● Public Price: | 144.35 EUR | ( 13,984,050.60 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 2,4058 EUR | ( 193,752.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 60 | |
● Public Price: | 153.24 EUR | ( 14,845,278.24 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 2,554 EUR | ( 193,752.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | The Netherlands | |
● Package Size: | 60 | |
● Public Price: | 148.59 EUR | ( 14,394,804.84 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 2,4765 EUR | ( 193,752.00 LBP ) |
● Pharmacy Price: | 141.59 EUR | ( 13716672.84 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 60 | |
● Public Price: | 101.41 EUR | ( 9,824,195.16 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 1,6902 EUR | ( 96,876.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 60 | |
● Public Price: | 87.32 EUR | ( 8,459,212.32 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 1,4553 EUR | ( 96,876.00 LBP ) |
● Exfactory Price: | 65.44 EUR | |
● Pharmacy Price: | 68.65 EUR | ( 6650537.4 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 60 | |
● Public Price: | 102.51 EUR | ( 9,930,758.76 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 1,7085 EUR | ( 96,876.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
● Country: | Turkey | |
● Package Size: | 60 | |
● Public Price: | 484.38 TRY | ( 1,298,138.40 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 8,073 TRY | ( 21,440.00 LBP ) |
● Pricing Date: | 28/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Portugal |
● Package Size: | 60 |
● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde |
● Pricing Date: | 22/04/2019 |
Note
You have to register to view this info
Drop File